XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 936 $ 56,279 $ 309,764 $ 675 $ 367,654 $ 14,999 $ 382,653
Common shares outstanding at Dec. 31, 2020 9,363,717            
 Stock option grant compensation $ 0 17 0 0 17 0 17
 Restricted stock compensation 0 135 0 0 135 0 135
 Shares granted to Employees 0 50 0 0 50 0 $ 50
Common shares granted, employees             1,098
 Restricted stock award 3 (3) 0 0 0 0 $ 0
Restricted stock award             27,778
 Net income 0 0 28,373 0 28,373 12,502 $ 40,875
 Distributions to partners 0 0 0 0 0 (170) (170)
 Unrealized loss on investment, net 0 0 0 (242) (242) 0 (242)
 Exercise of stock options 0 33 0 0 33 0 $ 33
Exercise of stock options             1,234
 Shares purchased and cancelled 0 (37) (227) 0 (264) 0 $ (264)
Shares purchased and cancelled             (6,004)
 Contributions from partners 0 0 0 0 0 4,548 $ 4,548
Ending balance, value at Mar. 31, 2021 $ 939 56,474 337,910 433 395,756 31,879 427,635
Common shares outstanding at Mar. 31, 2021 9,387,823            
Beginning balance, value at Dec. 31, 2020 $ 936 56,279 309,764 675 367,654 14,999 382,653
Common shares outstanding at Dec. 31, 2020 9,363,717            
Ending balance, value at Dec. 31, 2021 $ 941 57,617 337,752 113 396,423 28,827 $ 425,250
Common shares outstanding at Dec. 31, 2021 9,411,028           9,411,028
 Stock option grant compensation $ 0 17 0 0 17 0 $ 17
 Restricted stock compensation 0 130 0 0 130 0 130
 Shares granted to Employees 0 50 0 0 50 0 $ 50
Common shares granted, employees             865
 Restricted stock award 2 (2) 0 0 0 0 $ 0
Restricted stock award             21,464
 Forfeiture of restricted stock award 0 0 0 0 0 0 $ 0
Forfeited restricted shares             (1,363)
 Net income 0 0 672 0 672 (268) $ 404
 Distributions to partners 0 0 0 0 0 (771) (771)
 Unrealized loss on investment, net 0 0 0 (850) (850) 0 (850)
Ending balance, value at Mar. 31, 2022 $ 943 $ 57,812 $ 338,424 $ (737) $ 396,442 $ 27,788 $ 424,230
Common shares outstanding at Mar. 31, 2022 9,431,994           9,431,994